Perl Jessica has filed 7 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 104282 shares of Emergent BioSolutions Inc. ($EBS) on April 29, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 29, 2026 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | A | Common Stock | 104282 | $0.00 | 165,286.0000 | 56,700,000 | 170.94% | 0.18% |
| March 5, 2026 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | F | Common Stock | 6465 | $8.44 | 61,004.0000 | 56,700,000 | 9.58% | 0.01% |
| March 3, 2026 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | A | Employee Stock Option (Right to buy) | 46702 | $0.00 | 142,647.0000 | 56,700,000 | 48.68% | 0.08% |
| Feb. 9, 2026 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | F | Common Stock | 918 | $11.03 | 67,469.0000 | 56,700,000 | 1.34% | 0.00% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | A | Common Stock | 62500 | $0.00 | 68,387.0000 | 53,000,000 | 1061.66% | 0.12% |
| March 6, 2025 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 95,945.0000 | 53,000,000 | 186.87% | 0.12% |
| Feb. 9, 2025 | Emergent BioSolutions Inc. | $EBS | Perl Jessica | SVP, General Counsel, Corp Sec | F | Common Stock | 918 | $10.00 | 5,887.0000 | 53,000,000 | 13.49% | 0.00% |